Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cells
Titel:
Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cells
Auteur:
You, Fengtao Jiang, Licui Zhang, Bozhen Lu, Qiang Zhou, Qiao Liao, Xiaoyang Wu, Hong Du, Kaiqi Zhu, Youcai Meng, Huimin Gong, Zhishu Zong, Yunhui Huang, Lei Lu, Man Tang, Jirong Li, Yafen Zhai, Xiaochen Wang, Xiangling Ye, Sisi Chen, Dan Yuan, Lei Qi, Lin Yang, Lin